Author Correction: Suppression of Transposable Elements in Leukemic Stem Cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Author Correction: Suppression of Transposable Elements in Leukemic Stem Cells ; volume:8 ; number:1 ; day:6 ; month:3 ; year:2018 ; pages:1 ; date:12.2018
Scientific reports ; 8, Heft 1 (6.3.2018), 1, 12.2018
- Urheber
-
Colombo, Anthony R.
- Beteiligte Personen und Organisationen
-
Zubair, Asif
Thiagarajan, Devi
Nuzhdin, Sergey
Triche, Timothy J.
Ramsingh, Giridharan
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-21280-6
- URN
-
urn:nbn:de:1111-201805111763
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-14T10:50:07+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Colombo, Anthony R.
- Zubair, Asif
- Thiagarajan, Devi
- Nuzhdin, Sergey
- Triche, Timothy J.
- Ramsingh, Giridharan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Suppression of Transposable Elements in Leukemic Stem Cells
Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness
Understanding of leukemic stem cells and their clinical implications
Suppression of microtubule acetylation mediates the anti-leukemic effect of CDK9 inhibition
The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors
Proteinase-Activated Receptor 1 (PAR1) Regulates Leukemic Stem Cell Functions
PHF6 suppresses self-renewal of leukemic stem cells in AML
Transposable elements
Transposable elements activation triggers necroptosis in mouse embryonic stem cells
Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles
Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
Single cells and transposable element heterogeneity in stem cells and development
Suppression of Transposable Elements in Leukemic Stem Cells
Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness
Understanding of leukemic stem cells and their clinical implications
Suppression of microtubule acetylation mediates the anti-leukemic effect of CDK9 inhibition
The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors
Proteinase-Activated Receptor 1 (PAR1) Regulates Leukemic Stem Cell Functions
PHF6 suppresses self-renewal of leukemic stem cells in AML
Transposable elements
Transposable elements activation triggers necroptosis in mouse embryonic stem cells
Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles
Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
Single cells and transposable element heterogeneity in stem cells and development
Suppression of Transposable Elements in Leukemic Stem Cells
Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness
Understanding of leukemic stem cells and their clinical implications
Suppression of microtubule acetylation mediates the anti-leukemic effect of CDK9 inhibition
The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors
Proteinase-Activated Receptor 1 (PAR1) Regulates Leukemic Stem Cell Functions
PHF6 suppresses self-renewal of leukemic stem cells in AML
Transposable elements
Transposable elements activation triggers necroptosis in mouse embryonic stem cells
Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles
Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia